Nuclidium
ID: 13186847Nuclidium is a copper-based radiopharmaceutical platform founded in 2017 by Leila Jaafar Thiel.
1
Funding Rounds
$98.0m
Money raised
Recent Funding Rounds
Overview
Nuclidium is a copper-based radiopharmaceutical platform founded in 2017 by Leila Jaafar Thiel.
- Website:
- Business model: B2B
- Headquarters: Basel
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Le*** Ja**** Th*** |
|
- | |
| Gu**** vo* Sc******** |
|
- |
Funding series
Funding Series Analysis
The company Nuclidium has raised a total of $98m in funding over 1 rounds.
Key Insights:
- Nuclidium Series B Round, July 2025: $98m